Sanofi has announced that it will be expanding its immunology capabilities by acquiring US-based Blueprint Medicines ...

Lilly’s Omvoh is already recommended by NICE to treat certain cases of ulcerative colitis, another of the two main forms of ...

While sounding like an obvious statement, strategic planning is pivotal in shaping long-term success. However, given the lack ...

Pfizer has shared positive survival results from a late-stage study of its Braftovi (encorafenib) regimen in patients with ...

The key to success lies in striking the right balance: leveraging AI’s capabilities while maintaining the human elements that ...